It is important to note, however, that the anti-tumor effects of CXCL9 + macrophages likely extend beyond direct interactions with tumor cells and may also involve indirect modulation of other immune cells, such as T cells, NK cells, and B cells. The gene discussed is CXCL9; the disease is neoplasm.